10x Genomics TXG Income Statement (2018-2026)

NASDAQ TXG
$62.65 -0.57 (-0.90%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

10x Genomics Quarterly Income Statement

Periods 32 quarters
Latest Jun 2026

10x Genomics reported revenue of $151.04M and net income of -$17.93M for the quarter ended Jun 2026, down 12.6% year over year. This income statement covers 32 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
125.30M143.53M114.50M114.61M131.07M156.23M134.28M146.82M153.64M183.98M141.01M153.10M151.65M165.02M154.88M172.91M149.00M166.03M150.84M151.04M
Cost of RevenueCost of Rev
24.52M27.60M25.48M27.70M30.38M36.83M35.90M47.21M58.12M68.20M48.09M48.88M45.26M54.07M49.44M47.82M48.70M52.98M44.66M38.54M
Gross Profit
100.78M115.93M89.02M86.91M100.69M119.41M98.39M99.61M95.53M115.78M92.91M104.22M106.39M110.95M105.44M125.08M100.31M113.05M106.18M112.50M
Operating items
Research & DevelopmentR&D
54.58M61.88M64.08M70.69M67.29M63.61M67.10M71.46M66.51M65.27M68.64M62.92M66.17M66.97M64.25M61.22M57.19M55.97M56.85M56.79M
Selling, General & AdministrativeSG&A
62.08M69.88M66.67M79.34M73.40M78.89M83.28M91.51M82.42M86.12M85.77M83.04M81.70M93.83M89.73M74.43M75.36M76.62M66.38M78.66M
Other Operating ExpensesOther Opex
41.40M19.58M-9.20M-40.70M-3.40M
Operating ExpensesOpex
116.66M131.76M130.75M150.02M140.69M142.50M150.38M162.97M190.32M170.97M154.41M145.96M147.88M160.79M144.77M94.96M132.55M132.59M123.22M132.05M
Operating IncomeOp. Inc
-15.88M-15.83M-41.73M-63.12M-40.00M-23.10M-51.99M-63.36M-94.80M-55.19M-61.50M-41.74M-41.48M-49.84M-39.33M30.13M-32.24M-19.54M-17.05M-19.55M
EBIT
-15.88M-15.83M-41.73M-63.12M-40.00M-23.10M-51.99M-63.36M-94.80M-55.19M-61.50M-41.74M-41.48M-49.84M-39.33M30.13M-32.24M-19.54M-17.05M-19.55M
Non-operating items
Non Operating Interest Expenses
0.22M0.22M0.13M0.11M0.11M0.12M0.02M0.01M0.00M0.01M0.00M0.00M0.00M0.00M-0.00M
Interest & Investment IncomeInt & Inv Inc
0.05M0.05M0.57M1.24M2.02M2.81M3.87M4.10M4.30M4.62M4.74M4.71M4.97M4.51M3.69M4.27M5.20M6.89M5.01M4.80M
Other Non Operating IncomeOther Non Op Inc.
-0.60M0.01M-0.40M-1.84M-1.95M4.00M-1.52M-1.50M-1.25M3.98M-1.04M-0.06M2.08M-3.05M2.14M2.60M-1.17M-2.54M-0.81M-3.89M
Non Operating IncomeNon Op. Inc.
-0.77M-0.16M0.04M-0.71M-0.04M6.68M2.33M2.59M3.05M8.59M3.69M4.66M7.05M1.46M5.82M6.87M4.04M4.35M4.20M0.91M
Net income details
EBT
-16.65M-15.99M-41.69M-63.83M-40.03M-16.41M-49.65M-60.77M-91.74M-46.60M-57.80M-37.08M-34.44M-48.38M-33.51M37.00M-28.20M-15.19M-12.85M-18.64M
Tax ProvisionsTaxes
0.52M2.46M0.72M0.63M1.88M0.80M1.09M1.65M1.24M2.35M2.15M0.82M1.31M0.65M0.85M2.46M-0.73M1.06M0.62M-0.71M
Profit After TaxPAT
-17.17M-18.45M-42.41M-64.46M-41.91M-17.21M-50.75M-62.41M-92.99M-48.95M-59.95M-37.90M-35.75M-49.03M-34.36M34.54M-27.47M-16.25M-13.47M-17.93M
Income from Continuing OperationsIncome (Continuing)
-17.17M-18.45M-42.41M-64.46M-41.91M-17.21M-50.75M-62.41M-92.99M-48.95M-59.95M-37.90M-35.75M-49.03M-34.36M34.54M-27.47M-16.25M-13.47M-17.93M
Consolidated Net IncomeConsol Net Inc.
-17.17M-18.45M-42.41M-64.46M-41.91M-17.21M-50.75M-62.41M-92.99M-48.95M-59.95M-37.90M-35.75M-49.03M-34.36M34.54M-27.47M-16.25M-13.47M-17.93M
Income towards Parent CompanyParent Net Inc
-17.17M-18.45M-42.41M-64.46M-41.91M-17.21M-50.75M-62.41M-92.99M-48.95M-59.95M-37.90M-35.75M-49.03M-34.36M34.54M-27.47M-16.25M-13.47M-17.93M
Net Income towards Common StockholdersNet Income
-17.17M-18.45M-42.41M-64.46M-41.91M-17.21M-50.75M-62.41M-92.99M-48.95M-59.95M-37.90M-35.75M-49.03M-34.36M34.54M-27.47M-16.25M-13.47M-17.93M
Additional items
EPS (Basic)
-0.15-0.17-0.38-0.57-0.37-0.15-0.44-0.53-0.79-0.42-0.50-0.32-0.30-0.41-0.280.28-0.22-0.13-0.10-0.14
EPS (Diluted)
-0.15-0.17-0.38-0.57-0.37-0.15-0.44-0.53-0.79-0.42-0.50-0.32-0.30-0.41-0.280.28-0.22-0.13-0.10-0.14
Shares Outstanding
110.87M110.35M112.97M113.57M114.11M113.86M115.62M116.71M117.73M117.17M119.39M120.07M120.73M120.45M122.61M123.76M125.50M124.75M128.29M129.98M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
110.87M110.35M112.97M113.57M114.11M113.86M115.62M116.71M117.73M117.17M119.39M120.07M120.73M120.45M122.61M124.51M125.50M124.75M128.29M129.98M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
111.54M112.51M113.28M113.89M114.43M115.20M116.17M117.32M118.20M119.10M119.70M120.47M121.04M122.29M123.13M124.44M126.54M127.69M128.99M130.28M
EBITDA
-15.88M-15.83M-41.73M-63.12M-40.00M-23.10M-51.99M-63.36M-94.80M-55.19M-61.50M-41.74M-41.48M-49.84M-39.33M30.13M-32.24M-19.54M-17.05M-19.55M
Interest ExpensesInt Expense
0.22M0.22M0.13M0.11M0.11M0.12M0.02M0.01M0.00M0.01M0.00M0.00M0.00M0.00M-0.00M
Tax Rate
-3.14%-15.36%-1.72%-0.98%-4.69%-4.90%-2.20%-2.71%-1.35%-5.05%-3.71%-2.21%-3.82%-1.34%-2.54%6.65%2.60%-6.97%-4.85%3.83%